LOGO
LOGO

Earnings News

Pre-market Movers For July 13 (JPM, WFC, QCOR, ACAD, IGTE)

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Gainers:

JPMorgan Chase & Co. (JPM) is rising 0.79 percent to $34.31. The company's second quarter profit declined from the year-ago quarter. Total net revenue decreased from the previous year period, but topped Wall Street view. The company also announced that it will restate its previously-filed interim financial statements for the first quarter of 2012.

Wells Fargo & Co. (WFC) is up 0.76 percent to $33.10. The company's second quarter profit improved from the previous year period. Total revenue improved from the year-ago quarter, but missed the consensus estimate.

Questcor Pharmaceuticals, Inc. (QCOR) is rising over 3 percent to $46.92.

Decliners:

ACADIA Pharmaceuticals Inc. (ACAD) is down over 7 percent to $1.64. The company announced that AM-831, a compound under development for schizophrenia in collaboration with Meiji Seika Pharma Co., Ltd., did not meet the pre-determined criteria for further development in Phase I testing. As a result, the parties jointly have decided to discontinue the development of AM-831.

iGATE Corp. (IGTE) is down 3 percent to $15.50. The company's second quarter profit improved from the comparable period last year. However, the company's adjusted earnings per share missed Wall Street view. Revenues surged 57.3 percent, but missed the consensus by a whisker.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.
Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19